The HCV polymerase enzyme (NS5B) plays an important role in the viral cycle and it has been targeted for the development of compounds with antiviral activity. In our efforts to find hits as starting points for our drug discovery program, we utilized a HTS approach and fragment screening. In this talk, it will be described the approach we took to generate leads. This approach consisted of the design of new leads based on a model built with the primary interactions of a fragment and other known binders in the allosteric site Palm I.

Design of HCV NS5B Palm I allosteric site binders using a structure-based lead generation approach

244th National Meeting (2012)

The official archive and repository for all ACS Meetings & Expositions abstracts and select posters or presentations.